logo
About Us
Company Profile Development History Core Team Business Layout Honor Qualification Cooperation Models Partner
News and Information
Enterprise News Industry Trends
Product Technology
Product Introduction Core Patent Technology Technical Efficiency Verification Product Management Line R&D Platform
Talent Recruitment
Contact Us
EN -CN
logo
Homepage
About Us
Company Profile
Development History
Core Team
Business Layout
Honor Qualification
Cooperation Models
Partner
News and Information
Enterprise News
Industry Trends
Product Technology
Product Introduction
Core Patent Technology
Technical Efficiency Verification
Product Management Line
R&D Platform
Talent Recruitment
Contact Us
Homepage > News and Information > Enterprise News > News Details
Good News | Wankesen Granted New Patent Authorization for 'A Kind of Sturgeon Parvovirus Recombinant G2 Protein and Its Application'
Release time：2021-11-30 09:00:00
Enterprise News
Leading with Innovation, Promising Future Prospects

A Kind of Sturgeon Parvovirus Recombinant G2 Protein and Its Application.jpg

Prev：Wankesen Obtains New Patent Authorization for 'An Aquatic Animal Immune System and Its Application'

 Back to-News and Information-List

Next：No Data.
Contact Us
Learn more details
About Us News and Information Product Technology Talent Recruitment Contact Us

WeChat Scan QR Code
Follow Vance

All rights reserved © Shenzhen Wankesen Biotechnology Co., Ltd.

Yue ICP Filing No. 2025457595-1
Add. B Block 615-620, Key Laboratory Platform Building, Virtual University, Nanshan District, Shenzhen City